12-110913199-AG-AGG
Position:
Variant summary
Our verdict is Benign. Variant got -16 ACMG points: 0P and 16B. BP6_Very_StrongBA1
The NM_000432.4(MYL2):c.353+46_353+47insC variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0773 in 1,593,392 control chromosomes in the GnomAD database, including 5,554 homozygotes. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.078 ( 495 hom., cov: 32)
Exomes 𝑓: 0.077 ( 5059 hom. )
Consequence
MYL2
NM_000432.4 intron
NM_000432.4 intron
Scores
Not classified
Clinical Significance
Conservation
PhyloP100: -0.228
Genes affected
MYL2 (HGNC:7583): (myosin light chain 2) This gene encodes a major sarcomeric protein in mammalian striated muscle. The encoded protein plays a role in embryonic heart muscle structure and function, while phosphorylation of the encoded protein is involved in cardiac myosin cycling kinetics, torsion and function in adults. Mutations in this gene are associated with hypertrophic cardiomyopathy 10 and infant-onset myopathy. [provided by RefSeq, May 2022]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -16 ACMG points.
BP6
Variant 12-110913199-A-AG is Benign according to our data. Variant chr12-110913199-A-AG is described in ClinVar as [Benign]. Clinvar id is 31775.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.201 is higher than 0.05.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
MYL2 | NM_000432.4 | c.353+46_353+47insC | intron_variant | ENST00000228841.15 | NP_000423.2 | |||
MYL2 | NM_001406745.1 | c.311+46_311+47insC | intron_variant | NP_001393674.1 | ||||
MYL2 | NM_001406916.1 | c.296+46_296+47insC | intron_variant | NP_001393845.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
MYL2 | ENST00000228841.15 | c.353+46_353+47insC | intron_variant | 1 | NM_000432.4 | ENSP00000228841 | P1 | |||
MYL2 | ENST00000548438.1 | c.311+46_311+47insC | intron_variant | 3 | ENSP00000447154 | |||||
MYL2 | ENST00000663220.1 | c.296+46_296+47insC | intron_variant | ENSP00000499568 | ||||||
MYL2 | ENST00000549029.1 | n.230_231insC | non_coding_transcript_exon_variant | 2/2 | 2 |
Frequencies
GnomAD3 genomes AF: 0.0784 AC: 11027AN: 140630Hom.: 496 Cov.: 32
GnomAD3 genomes
AF:
AC:
11027
AN:
140630
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.0742 AC: 18258AN: 245936Hom.: 1186 AF XY: 0.0778 AC XY: 10352AN XY: 133050
GnomAD3 exomes
AF:
AC:
18258
AN:
245936
Hom.:
AF XY:
AC XY:
10352
AN XY:
133050
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0772 AC: 112089AN: 1452666Hom.: 5059 Cov.: 41 AF XY: 0.0791 AC XY: 57214AN XY: 723320
GnomAD4 exome
AF:
AC:
112089
AN:
1452666
Hom.:
Cov.:
41
AF XY:
AC XY:
57214
AN XY:
723320
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0784 AC: 11028AN: 140726Hom.: 495 Cov.: 32 AF XY: 0.0808 AC XY: 5565AN XY: 68862
GnomAD4 genome
AF:
AC:
11028
AN:
140726
Hom.:
Cov.:
32
AF XY:
AC XY:
5565
AN XY:
68862
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
ClinVar
Significance: Benign
Submissions summary: Benign:3Other:1
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:1Other:1
not provided, no classification provided | curation | Leiden Muscular Dystrophy (MYL2) | Mar 26, 2012 | - - |
Benign, criteria provided, single submitter | clinical testing | GeneDx | Jun 23, 2018 | - - |
not specified Benign:1
Benign, criteria provided, single submitter | clinical testing | PreventionGenetics, part of Exact Sciences | - | - - |
Primary familial hypertrophic cardiomyopathy Benign:1
Benign, no assertion criteria provided | clinical testing | Women's Health and Genetics/Laboratory Corporation of America, LabCorp | Apr 28, 2015 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at